CLINICAL_TRIALS
trial_result
· 2013-06-05
Clinical Trial Update: Late Phase 2 Study of OPC-12759 Ophthalmic Suspension [Phase 2]
Summary
A Phase 2 trial of OPC-12759 ophthalmic suspension for dry eye syndromes has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2013-06-05